PARALLAX HEALTH SCIENCES, INC. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 11 rows, 11 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-11-06: Reporting owner WITHROW EDWARD W III; Form 5; Security PREFERRED STOCK (SERIES A); Transaction J Other acquisition or disposition (describe transaction).
- 2021-11-06: Reporting owner WITHROW EDWARD W III; Form 5; Security PREFERRED STOCK (SERIES A); Transaction J Other acquisition or disposition (describe transaction).
- 2019-01-23: Reporting owner Gorlach Jorn; Form 5; Security WARRANTS (PREFERRED SERIES B); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2018-09-30: Reporting owner BRADLEY NATHANIEL T; Form 5; Security PREFERRED STOCK (SERIES C); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-11-06 | WITHROW EDWARD W III 10% Owner | 5 | PREFERRED STOCK (SERIES A) Non-derivative · Indirect · By Huntington Chase Financial Group | J Other acquisition or disposition (describe transaction) | +396,339 796,071 owned after | $0.00 | 2022-03-17 | |
| 2021-11-06 | WITHROW EDWARD W III 10% Owner | 5 | PREFERRED STOCK (SERIES A) Non-derivative · Indirect · By Huntington Chase Financial Group | J Other acquisition or disposition (describe transaction) | −796,071 0 owned after | $0.00 | 2022-03-17 | |
| 2019-01-23 | Gorlach Jorn 10% Owner | 5 | WARRANTS (PREFERRED SERIES B) Derivative · Indirect · By Hamburg Investment Co | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 3,770,893 owned after | $0.25 exercise price | 2020-03-04 | |
| 2018-09-30 | BRADLEY NATHANIEL T | 5 | PREFERRED STOCK (SERIES C) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 2,455,000 owned after | $5.00 | 2019-01-15 | |
| 2018-09-30 | ARENA PAUL R Director, Officer (CEO, President) | 5 | PREFERRED STOCK (SERIES C) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 5,030,000 owned after | $5.00 | 2019-01-15 | |
| 2018-09-30 | BUCCI CALLI Director, Officer (CFO) | 5 | PREFERRED STOCK (SERIES C) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 1,030,000 owned after | $5.00 | 2019-01-15 | |
| 2017-01-23 | Gorlach Jorn 10% Owner | 5 | PREFERRED STOCK (SERIES B) Derivative · Indirect · By Hamburg Investment Co | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 393,393 owned after | $5.00 | 2019-01-28 | |
| 2017-01-23 | Gorlach Jorn 10% Owner | 5 | WARRANTS (PREFERRED SERIES B) Derivative · Indirect · By Hamburg Investment Co | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 408,393 owned after | $0.75 exercise price | 2019-01-28 | |
| 2014-01-07 holding as of filing | Gorlach Jorn Director, 10% Owner | 5/A | PREFERRED STOCK Non-derivative · Indirect · By Hamburg Investment Corp. | Holding | 399,732 owned after | no price filed | 2014-01-07 | |
| 2014-01-07 holding as of filing | WITHROW EDWARD W III Director, 10% Owner | 5/A | PREFERRED STOCK Non-derivative · Indirect · By Huntington Chase Financial Group | Holding | 363,393 owned after | no price filed | 2014-01-07 | |
| 2011-09-30 | WITHROW EDWARD W III 10% Owner | 5 | PREFERRED STOCK (SERIES A) Non-derivative · Indirect · By Huntington Chase Financial Group | J Other acquisition or disposition (describe transaction) | +36,339 399,732 owned after | $2.75 | 2022-03-17 |